142 related articles for article (PubMed ID: 11212099)
1. Sulfonylated aminothiazoles as new small molecule inhibitors of protein phosphatases.
Wipf P; Aslan DC; Southwick EC; Lazo JS
Bioorg Med Chem Lett; 2001 Feb; 11(3):313-7. PubMed ID: 11212099
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.
Sodeoka M; Sampe R; Kojima S; Baba Y; Usui T; Ueda K; Osada H
J Med Chem; 2001 Sep; 44(20):3216-22. PubMed ID: 11563920
[TBL] [Abstract][Full Text] [Related]
3. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
4. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
[TBL] [Abstract][Full Text] [Related]
5. Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.
Lazo JS; Nunes R; Skoko JJ; Queiroz de Oliveira PE; Vogt A; Wipf P
Bioorg Med Chem; 2006 Aug; 14(16):5643-50. PubMed ID: 16698271
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of newly synthesized quinoline-5,8-quinones as Cdc25B inhibitors.
Cossy J; Belotti D; Brisson M; Skoko JJ; Wipf P; Lazo JS
Bioorg Med Chem; 2006 Sep; 14(18):6283-7. PubMed ID: 16782352
[TBL] [Abstract][Full Text] [Related]
7. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
[TBL] [Abstract][Full Text] [Related]
8. The solid phase synthesis of tetrahydroisoquinolines having cdc25B inhibitory activity.
Fritzen EL; Brightwell AS; Erickson LA; Romero DL
Bioorg Med Chem Lett; 2000 Apr; 10(7):649-52. PubMed ID: 10762045
[TBL] [Abstract][Full Text] [Related]
9. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening.
Duval R; Kolb S; Braud E; Genest D; Garbay C
J Comb Chem; 2009; 11(6):947-50. PubMed ID: 19835352
[No Abstract] [Full Text] [Related]
10. Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
Lazo JS; Skoko JJ; Werner S; Mitasev B; Bakan A; Koizumi F; Yellow-Duke A; Bahar I; Brummond KM
J Pharmacol Exp Ther; 2007 Sep; 322(3):940-7. PubMed ID: 17538006
[TBL] [Abstract][Full Text] [Related]
11. 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.
Klopfenstein SR; Evdokimov AG; Colson AO; Fairweather NT; Neuman JJ; Maier MB; Gray JL; Gerwe GS; Stake GE; Howard BW; Farmer JA; Pokross ME; Downs TR; Kasibhatla B; Peters KG
Bioorg Med Chem Lett; 2006 Mar; 16(6):1574-8. PubMed ID: 16386905
[TBL] [Abstract][Full Text] [Related]
12. Quinoxalinylurea derivatives as a novel class of JSP-1 inhibitors.
Zhang L; Qiu B; Xiong B; Li X; Li J; Wang X; Li J; Shen J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2118-22. PubMed ID: 17303416
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
[TBL] [Abstract][Full Text] [Related]
14. RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1phase.
Hamaguchi T; Sudo T; Osada H
FEBS Lett; 1995 Sep; 372(1):54-8. PubMed ID: 7556642
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
16. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase.
Brisson M; Nguyen T; Vogt A; Yalowich J; Giorgianni A; Tobi D; Bahar I; Stephenson CR; Wipf P; Lazo JS
Mol Pharmacol; 2004 Oct; 66(4):824-33. PubMed ID: 15231869
[TBL] [Abstract][Full Text] [Related]
17. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
[TBL] [Abstract][Full Text] [Related]
18. Naphthoquinone analogs as inactivators of cdc25 phosphatase.
Ham SW; Park J; Lee SJ; Kim W; Kang K; Choi KH
Bioorg Med Chem Lett; 1998 Sep; 8(18):2507-10. PubMed ID: 9873570
[TBL] [Abstract][Full Text] [Related]
19. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors.
Lazo JS; Nemoto K; Pestell KE; Cooley K; Southwick EC; Mitchell DA; Furey W; Gussio R; Zaharevitz DW; Joo B; Wipf P
Mol Pharmacol; 2002 Apr; 61(4):720-8. PubMed ID: 11901209
[TBL] [Abstract][Full Text] [Related]
20. Discovery of protein kinase phosphatase inhibitors.
Vogt A; Lazo JS
Methods Mol Biol; 2007; 356():389-400. PubMed ID: 16988418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
